FP 7832
Alternative Names: FP-7832Latest Information Update: 06 Jun 2007
At a glance
- Originator Faust Pharmaceuticals
- Class
- Mechanism of Action Cholinergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 06 Jun 2007 Discontinued - Preclinical for Alzheimer's disease in France (unspecified route)
- 14 Jan 2004 Preclinical trials in Alzheimer's disease in France (unspecified route)